MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor

Immunity

Volumn 45, Issue 1, 2016, Pages 83-93

  Yang, Huang Yu ^a,b   Barbi, Joseph ^a,c   Wu, Chao Yi ^a,b   Zheng, Ying ^a,d   Vignali, Paolo D A ^a   Wu, Xingmei ^a,d   Tao, Jin Hui ^a   Park, Benjamin V ^a   Bandara, Shashika ^a   Novack, Lewis ^a   Ni, Xuhao ^a   Yang, Xiaoping ^a   Chang, Kwang Yu ^a,e   Wu, Ren Chin ^b   Zhang, Junran ^f   Yang, Chih Wei ^b   Pardoll, Drew M ^a   Li, Huabin ^d   Pan, Fan ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e National Institute of Cancer Research   (Taiwan)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EOS PROTEIN; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; L SELECTIN; LYMPHOID ENHANCER FACTOR 1; MICRORNA; MICRORNA 17; MICRORNA 17 92; PROTEIN; SATB1 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; MIRN17-92 MICRORNA, MOUSE; NERVE PROTEIN; ZFPN1A4 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECTOPIC EXPRESSION; EXPERIMENTAL COLITIS; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; COLITIS; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; COLITIS; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; NERVE TISSUE PROTEINS; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 84990836182     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.06.022     Document Type: Article

References (55)

1. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006), 235–238.
2. Bettini, M.L., Pan, F., Bettini, M., Finkelstein, D., Rehg, J.E., Floess, S., Bell, B.D., Ziegler, S.F., Huehn, J., Pardoll, D.M., Vignali, D.A., Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36 (2012), 717–730.
3. Brock, M., Trenkmann, M., Gay, R.E., Michel, B.A., Gay, S., Fischler, M., Ulrich, S., Speich, R., Huber, L.C., Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res. 104 (2009), 1184–1191.
4. Chong, M.M., Rasmussen, J.P., Rudensky, A.Y., Littman, D.R., The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 205 (2008), 2005–2017.
5. Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.R., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146 (2011), 772–784.
6. Darce, J., Rudra, D., Li, L., Nishio, J., Cipolletta, D., Rudensky, A.Y., Mathis, D., Benoist, C., An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 36 (2012), 731–741.
7. de Kouchkovsky, D., Esensten, J.H., Rosenthal, W.L., Morar, M.M., Bluestone, J.A., Jeker, L.T., microRNA-17-92 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitis. J. Immunol. 191 (2013), 1594–1605.
8. Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H.D., Bopp, T., Schmitt, E., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol., 5, 2007, e38.
9. Fontenot, J.D., Rasmussen, J.P., Williams, L.M., Dooley, J.L., Farr, A.G., Rudensky, A.Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005), 329–341.
10. Fu, W., Ergun, A., Lu, T., Hill, J.A., Haxhinasto, S., Fassett, M.S., Gazit, R., Adoro, S., Glimcher, L., Chan, S., et al. A multiply redundant genetic switch ‘locks in’ the transcriptional signature of regulatory T cells. Nat. Immunol. 13 (2012), 972–980.
11. Gao, Z., Gao, Y., Li, Z., Chen, Z., Lu, D., Tsun, A., Li, B., Synergy between IL-6 and TGF-β signaling promotes FOXP3 degradation. Int. J. Clin. Exp. Pathol. 5 (2012), 626–633.
12. Gijbels, K., Brocke, S., Abrams, J.S., Steinman, L., Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1 (1995), 795–805.
13. Goodman, W.A., Levine, A.D., Massari, J.V., Sugiyama, H., McCormick, T.S., Cooper, K.D., IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J. Immunol. 183 (2009), 3170–3176.
14. Hou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., Wang, Z., Cao, X., MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183 (2009), 2150–2158.
15. Jiang, S., Li, C., Olive, V., Lykken, E., Feng, F., Sevilla, J., Wan, Y., He, L., Li, Q.J., Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118 (2011), 5487–5497.
16. Kohlhaas, S., Garden, O.A., Scudamore, C., Turner, M., Okkenhaug, K., Vigorito, E., Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol. 182 (2009), 2578–2582.
17. Kretschmer, K., Apostolou, I., Verginis, P., von Boehmer, H., Regulatory T cells and antigen-specific tolerance. Chem. Immunol. Allergy 94 (2008), 8–15.
18. Lal, G., Zhang, N., van der Touw, W., Ding, Y., Ju, W., Bottinger, E.P., Reid, S.P., Levy, D.E., Bromberg, J.S., Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 182 (2009), 259–273.
19. Li, Q.J., Chau, J., Ebert, P.J., Sylvester, G., Min, H., Liu, G., Braich, R., Manoharan, M., Soutschek, J., Skare, P., et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129 (2007), 147–161.
20. Lindberg, R.L., Hoffmann, F., Mehling, M., Kuhle, J., Kappos, L., Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 40 (2010), 888–898.
21. Liston, A., Lu, L.F., O'Carroll, D., Tarakhovsky, A., Rudensky, A.Y., Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205 (2008), 1993–2004.
22. Lu, L.F., Thai, T.H., Calado, D.P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G.B., Lee, H., Yoshimura, A., Rajewsky, K., Rudensky, A.Y., Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30 (2009), 80–91.
23. Lu, L.F., Boldin, M.P., Chaudhry, A., Lin, L.L., Taganov, K.D., Hanada, T., Yoshimura, A., Baltimore, D., Rudensky, A.Y., Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142 (2010), 914–929.
24. Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H.J., Waldmann, H., Huehn, J., Hori, S., Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36 (2012), 262–275.
25. O'Connell, R.M., Rao, D.S., Chaudhuri, A.A., Baltimore, D., Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10 (2010), 111–122.
26. O'Shea, J.J., Paul, W.E., Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327 (2010), 1098–1102.
27. Ota, A., Tagawa, H., Karnan, S., Tsuzuki, S., Karpas, A., Kira, S., Yoshida, Y., Seto, M., Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64 (2004), 3087–3095.
28. Pan, F., Yu, H., Dang, E.V., Barbi, J., Pan, X., Grosso, J.F., Jinasena, D., Sharma, S.M., McCadden, E.M., Getnet, D., et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325 (2009), 1142–1146.
29. Pasare, C., Medzhitov, R., Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003), 1033–1036.
30. Quintana, F.J., Jin, H., Burns, E.J., Nadeau, M., Yeste, A., Kumar, D., Rangachari, M., Zhu, C., Xiao, S., Seavitt, J., et al. Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat. Immunol. 13 (2012), 770–777.
31. Rubtsov, Y.P., Niec, R.E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., Rudensky, A.Y., Stability of the regulatory T cell lineage in vivo. Science 329 (2010), 1667–1671.
32. Rudra, D., deRoos, P., Chaudhry, A., Niec, R.E., Arvey, A., Samstein, R.M., Leslie, C., Shaffer, S.A., Goodlett, D.R., Rudensky, A.Y., Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 13 (2012), 1010–1019.
33. Sakaguchi, S., Miyara, M., Costantino, C.M., Hafler, D.A., FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10 (2010), 490–500.
34. Sakaguchi, S., Vignali, D.A., Rudensky, A.Y., Niec, R.E., Waldmann, H., The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13 (2013), 461–467.
35. Sharma, M.D., Huang, L., Choi, J.H., Lee, E.J., Wilson, J.M., Lemos, H., Pan, F., Blazar, B.R., Pardoll, D.M., Mellor, A.L., et al. An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity 38 (2013), 998–1012.
36. Shen, H., Goldstein, D.R., IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J. Am. Soc. Nephrol. 20 (2009), 1032–1040.
37. Stefani, G., Slack, F.J., Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 9 (2008), 219–230.
38. Tagawa, H., Seto, M., A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19 (2005), 2013–2016.
39. Takahashi, H., Kanno, T., Nakayamada, S., Hirahara, K., Sciumè, G., Muljo, S.A., Kuchen, S., Casellas, R., Wei, L., Kanno, Y., O'Shea, J.J., TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells. Nat. Immunol. 13 (2012), 587–595.
40. Tang, Q., Bluestone, J.A., The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9 (2008), 239–244.
41. Tsuji, M., Komatsu, N., Kawamoto, S., Suzuki, K., Kanagawa, O., Honjo, T., Hori, S., Fagarasan, S., Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 323 (2009), 1488–1492.
42. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006), 179–189.
43. Vignali, D.A., Collison, L.W., Workman, C.J., How regulatory T cells work. Nat. Rev. Immunol. 8 (2008), 523–532.
44. Wu, Y., Heinrichs, J., Bastian, D., Fu, J., Nguyen, H., Schutt, S., Liu, Y., Jin, J., Liu, C., Li, Q.J., et al. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice. Blood 126 (2015), 1314–1323.
45. Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J., Henderson, J.M., Kutok, J.L., Rajewsky, K., Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9 (2008), 405–414.
46. Xu, L., Kitani, A., Fuss, I., Strober, W., Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178 (2007), 6725–6729.
47. Yang, L., Anderson, D.E., Baecher-Allan, C., Hastings, W.D., Bettelli, E., Oukka, M., Kuchroo, V.K., Hafler, D.A., IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454 (2008), 350–352.
48. Yang, X.O., Nurieva, R., Martinez, G.J., Kang, H.S., Chung, Y., Pappu, B.P., Shah, B., Chang, S.H., Schluns, K.S., Watowich, S.S., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29 (2008), 44–56.
49. Zheng, S.G., Wang, J., Horwitz, D.A., Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 180 (2008), 7112–7116.
50. Zheng, Y., Chaudhry, A., Kas, A., deRoos, P., Kim, J.M., Chu, T.T., Corcoran, L., Treuting, P., Klein, U., Rudensky, A.Y., Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458 (2009), 351–356.
51. Zhou, L., Ivanov, I.I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D.E., Leonard, W.J., Littman, D.R., IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8 (2007), 967–974.
52. Zhou, L., Lopes, J.E., Chong, M.M., Ivanov, I.I., Min, R., Victora, G.D., Shen, Y., Du, J., Rubtsov, Y.P., Rudensky, A.Y., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453 (2008), 236–240.
53. Zhou, X., Jeker, L.T., Fife, B.T., Zhu, S., Anderson, M.S., McManus, M.T., Bluestone, J.A., Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205 (2008), 1983–1991.
54. Zhou, X., Bailey-Bucktrout, S., Jeker, L.T., Bluestone, J.A., Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 21 (2009), 281–285.
55. Ziegler, S.F., FOXP3: of mice and men. Annu. Rev. Immunol. 24 (2006), 209–226.